Intrinsiqq
Cardio Diagnostics Holdings Inc. logo

Cardio Diagnostics Holdings Inc. Intrinsic Value

CDIO

⊜ Compare

Choose a model

Each card values Cardio Diagnostics Holdings a different way, shown at our starting inputs. Pick one to see and change how it works.

Set your assumptions

Cardio Diagnostics Holdings on revenue: sales per share grow and the stock trades at a normal price-to-sales multiple. For companies not yet profitable.

Years to project

Growth of revenue per share

Revenue per share; starts at its own recent growth

Exit P/S

Starts at its industry's median P/S

Your desired return

Margin of safety

More

Your buy price

The expected return is measured from it; starts at today's price

How it's worked out

  1. Today's revenue per share

    Last twelve months

    $0.00

  2. Revenue in 2031

    Grows 0.0% a year for 5 years

    $0.00

  3. Price in 2031

    $0.00 × 2.4 P/S

    $0.01

  4. Worth today

    ÷ 1.10^5: your 10% a year, taken back out

    $0.01

  5. Fair value

    The most you can pay and still earn 10% a year

    $0.01

  6. Buy below

    Fair value minus your 25% margin of safety

    $0.01

Paying $1.65 instead gives -62.8% a year. Every rule is on the methodology page.

Outcome

What your assumptions give, and the path from today's price.

Fair value

$0.01

Expected return

-62.8% a year

Future price, 2031

$0.01

Buy below

$0.01

Price 22508% above fair valuePrice $1.65, at your 10% return

Projection

Solid blue: the price at each year end. Dashed blue: from today's price to the 2031 price. Green: from the fair value, rising at your 10% a year to the same end point; buy at or below it and you earn at least that. Every rule is on the methodology page. A model, not a forecast or advice.

Cardio Diagnostics Holdings (CDIO) intrinsic value and fair value

The calculator grows one of Cardio Diagnostics Holdings's per-share figures (earnings, free cash flow, revenue, book value or dividends) for a few years, puts an exit multiple on it, and discounts the result back at the yearly return you want. The answers below use its starting inputs for CDIO; this is analysis, not investment advice.

Frequently asked

What is Cardio Diagnostics Holdings's (CDIO) intrinsic value?+

With Intrinsiqq's starting inputs, Cardio Diagnostics Holdings's fair value is about $0.01 a share, based on its revenue per share. That assumes revenue per share of $0.00 grows about 0.0% a year for 5 years, the stock then trades at 2.4 times revenue, and you want a 10.0% yearly return. Every input can be changed on the page; the result is a model, not a forecast.

Is Cardio Diagnostics Holdings overvalued?+

At $1.65, the price is 22508% above that fair value of $0.01, and buying at today's price would return about -62.8% a year if those inputs hold. Whether that is cheap or dear depends on whether you believe the growth and the exit multiple, which is what the calculator lets you test. This is analysis from SEC filings, not investment advice.

What growth does the Cardio Diagnostics Holdings valuation assume?+

Revenue per share grows about 0.0% a year to start, its own recent growth per share (three years for a company not yet profitable, five otherwise). The exit multiple starts at its industry's median.

What is a good margin of safety for Cardio Diagnostics Holdings?+

A margin of safety is the cushion you want below the fair value before buying, in case the inputs are wrong. The calculator uses 25%, which puts the buy-below price at $0.01. Less predictable businesses deserve a wider cushion, or a higher desired return.

How the market compares: US profitability statistics

Peers

In Vitro & In Vivo Diagnostic Substances · Pick stocks to compare with CDIO

CompareIntrinsic value
ADTXAditxt Inc.
$0.00+33.33%20
NTRRNeutra Corp
$0.00+0.00%40
SKVISkinvisible Inc.
$0.16+0.00%0
GNLXGenelux Corp.
$1.96+2.08%10
JUNSJupiter Neurosciences Inc.
$2.46+1.23%10
SNTISenti Biosciences Inc.
$0.18-0.79%0
ASBPAspire Biopharma Holdings Inc.
$7.27-0.41%20
BDPTBioadaptives Inc.
$0.00-5.88%25

Spot a number that looks wrong? Check it in CDIO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CDIO

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.